R ODENT trophoblast cells synthesize DNA during two different cellular programs: proliferation and endoreduplication (l-6). Proliferation results in the expansion of trophoblast precursor cells that can differentiate along the trophoblast multilineage pathway (l-4). Endoreduplication is characterized by the continuation of DNA synthesis in the absence of cell division, resulting in the formation of trophoblast giant cells (5, 6) . Trophoblast giant cells represent one of the differentiated trophoblast cell lineages and possess a number of specialized functions, including the biosynthesis of steroid and peptide hormones (4-7). Steroid and peptide hormone production follow a stage-specific pattern and occur concomitantly with endoreduplication (7). The Rcho-1 trophoblast cell line provides a means of dissecting the trophoblast giant cell differentiation pathway (4, 8, 9) . Rcho-1 trophoblast cells can be manipulated to proliferate or differentiate @,9). Proliferating trophoblast cells can be maintained by culturing Rcho-1 trophoblast cells in the presence of fetal bovine serum (FBWsupplemented culture medium and preventing the cells from becoming confluent, whereas differentiation can be induced by substituting horse serum (HS) supplementation for FBS and increasing the density of the cultures (9). Differentiating Rcho-1 trophoblast cells undergo endoreduplication and a stage-specific pattern of expression of peptide and steroid hormones mimicking the behavior of trophoblast giant cells developing in situ (8-10). These initial observations suggested significant differences in the control of proliferating and differentiating trophoblast cells.
In the present report, we use the Rcho-1 trophoblast cell line to investigate the regulation of DNA synthesis in proliferating and differentiating trophoblast cells. Evidence is presented to support the notion of differential regulation of proliferating and differentiating trophoblast cells and for the involvement of transferrin, transforming growth factor-p (TGFP), and tyrosine kinase signaling pathways in the regulation of trophoblast cells. In the initial series of experiments, we compared the responses of stem and differentiating trophoblast cells to various extracellular modulators. The results presented below demonstrate that DNA synthesis is differentially regulated in proliferating and differentiating trophoblast cells.
Materials and Methods

Reagents
Serum supplementation
and DNA synthesis in stem and di'erentiating trophoblast cells. To obtain an initial understanding of the nature of the regulation of proliferating and differentiating trophoblast cells, we examined the effects of serum supplementation (FBS, HS, or serum free) on DNA synthesis by stem and differentiating Rcho-1 trophoblast cells. DNA synthesis in trophoblast stem cells was dependent on and significantly stimulated by the presence of serum (Fig. 1 ). FBS was a more potent stimulator of DNA synthesis than HS ( Fig.  1 ). In contrast, DNA synthesis in differentiating trophoblast cells was maximal under serum-free conditions ( Fig. 1 ). Supplementation with FBS was without effect, whereas HS ap-GROWTH AND DIFFERENTIATION peared to moderately inhibit DNA synthesis in differentiating trophoblast cells (Fig. 1 ).
Transferrin and DNA synthesis in stem and differentiating trophobzast ceZIs. Transferrin is known to be a significant growth regulatory component present in serum (17). In the next series of experiments, we examined the effects of transferrin on DNA synthesis and proliferation of Rcho-1 trophoblast stem cells and on DNA synthesis in differentiating Rcho-1 trophoblast cells. Transferrin significantly stimulated DNA synthesis in serum-deprived Rcho-1 trophoblast stem cells ( Fig. 2 ), but was not sufficient to promote their proliferation (data not shown). The EDso for transferrin-stimulated DNA synthesis was approximately 0.25 pg/ml (Fig. 2) . DNA synthesis in differentiating Rcho-1 trophoblast cells was not significantly affected by transferrin supplementation (Fig. 2 ).
Growth factors, DNA synthesis, and proliferation of trophoblast cells. Our initial experiments indicated the dependence of trophoblast stem cell DNA synthesis and proliferation on serum. Transferrin was identified as a stimulatory component, but was not sufficient to promote proliferation or maximal DNA synthesis (Fig. 2 ). In the following experiments, we investigated the actions of a number of different peptide growth factors on the proliferation and DNA synthesis of Rcho-1 trophoblast stem cells. Many of the factors tested in these experiments have been reported to be produced in the placenta or have been speculated to influence the behavior of trophoblast cells (18, 19 TGFPl had a modest, but significant, inhibitory effect on serum-stimulated Rcho-1 trophoblast stem cell DNA synthesis ( Fig. 3 ; P < 0.05) and a pronounced significant inhibitory effect on the proliferation of FBS-stimulated Rcho-1 trophoblast stem cells (Fig. 3 ). Significant inhibition of serum-stimulated proliferation was seen with doses of TGFPl at and above 0.01 rig/ml (P < 0.05). The ED,, for TGFPl inhibition of Rcho-1 trophoblast stem cell proliferation was between 0.01-0.05 rig/ml (Fig. 3) . TGFPl did not significantly influence DNA synthesis by differentiating Rcho-1 trophoblast cells maintained under serum-free or FBS-supplemented conditions (Fig. 3) .
Identification
of intracellular pathways controlling DNA synthesis in stem and differentiating trophoblast cells
The following series of experiments was designed to investigate signal transduction mechanisms involved in regulating DNA synthesis in proliferating and differentiating trophoblast cells. Preliminary experiments indicated that activators of protein kinase-C (phorbol12-myristate 12-acetate) and protein kinase-A (8-bromo-CAMP) athways had minimal effects on Rcho-1 trophoblast cell [ cp Hlthymidine incorporation or proliferation (data not shown). The results presented below implicate the involvement of tyrosine kinase pathways in the regulation of DNA synthesis of both proliferating and differentiating trophoblast cells.
Genistein and DNA synthesis in stem and differentiating trophobZust cells. Rcho-1 trophoblast cells were treated with the tyrosine kinase inhibitor, genistein, to assess the role of tyrosine kinases in regulating DNA synthesis during proliferation and differentiation. FBS or transferrin stimulated DNA synthesis in trophoblast stem cells, and DNA synthesis in differentiating trophoblast cells was significantly inhibited by genistein at concentrations of 10 PM and above ( Fig. 4 ; P < 0.05). The ED,, for the inhibition of (Fig. 4) . moval of the drug (data not shown). The related tyrosine Genistein was also an effective inhibitor of FBS-stimulated kinase inhibitor, lavendustin-A, was ineffective at influtrophoblast stem cell proliferation (Fig. 5) . The potency of encing the behavior of trophoblast stem or differentiating genistein in these assays was similar to its inhibitory accells at concentrations equivalent to or higher than those tions on DNA synthesis by Rcho-1 trophoblast stem cells.
used for genistein (data not shown). Tyvosine kinase activities in proliferating and differentiating trophoblast cells. A peptide containing a consensus tyrosine phosphorylation site from the tyrosine kinase c-SYC was used to examine tyrosine kinase activities in stem and differentiating trophoblast cells. Tyrosine kinase activities were detectable in both proliferating and differentiating trophoblast cells (Fig. 6 ). FBS-treated trophoblast stem cells possessed significantly higher tyrosine kinase activities than serumdeprived trophoblast stem cells (Fig. 6 ). Transferrin-treated trophoblast stem cells also showed significantly higher tyrosine kinase activities than serum-deprived trophoblast stem cells (Fig. 6 ). FBS-responsive tyrosine kinase activities were present in both membrane and cytosolic fractions, whereas transferrin-responsive tyrosine kinase activities were restricted to the membrane fraction (Fig. 6) . Tyrosine kinase activities were detectable in serum-deprived differentiating cultures and were significantly increased after FBS treatment (Fig. 6) trophoblast cells was modest compared to the response of trophoblast stem cells (Fig. 6 ).
Identification of putative substrates for tyrosine kinases present in proliferating and differentiating trophoblast cells. As both proliferating and differentiating trophoblast cells were responsive to a tyrosine kinase inhibitor and possessed tyrosine kinase activities, we next analyzed the spectrum of phosphotyrosine-containing proteins in each population of cells. GROWTH AND DIFFERENTIATION Endo . 1995 Vol 136. No 1 The distribution of phosphotyrosine-containing proteins present in differentially treated trophoblast stem cells was examined by Western blot analysis. After a 24-h exposure to serum-free medium, trophoblast stem cells were exposed to one of four treatments for an additional 24 h before they were harvested and analyzed for their distribution of phosphotyrosine-containing proteins. The treatments included 1) serum-free medium, 2) serum-free medium plus transferrin (10 pg/ml), 3) 10% FBS, and 4) 10% FBS plus TGFPl ( a PTyr a PTyr t PTyr rig/ml). Unique patterns of phosphotyrosine-containing proteins were evident for each treatment. Treatment with transferrin resulted in a decrease in the intensity of phosphotyrosine-containing proteins migrating at approximately 37 and 40 kilodaltons (kDa) and others between 50-60 kDa (compare lanes A and B of Fig. 7, top panel) . Treatment with FBS resulted in a further decrease in the phosphotyrosine content of the 37-, 40-, and 50-to 60-kDa species and an increase in the phosphotyrosine content of species migrating at approximately 38, 39, and 62 kDa (compare lanes A and C of Fig. 7, top panel) . TGFP-treated cells showed a pattern very similar to that of the FBS-treated cells except for the appearance of an additional phosphotyrosine-containing protein migrating at approximately 93 kDa (compare lanes C and D of Fig. 7, top panel) .
Western blot analyses of proliferating and differentiating trophoblast cell lysates with antiphosphotyrosine antibodies indicated different distributions of phosphotyrosine-containing proteins in each preparation (Fig. 7, bottom panel) .
Phosphoproteins of approximately 32,34, and 49 kDa were in greater abundance in proliferating trophoblast cells, whereas phosphoproteins of approximately 26,41,55,57,75, and 93 kDa were in greater abundance in differentiating trophoblast cells. The unique 93-kDa phosphotyrosine-containing species present in the TGFP-treated stem cells (see Fig. 7 , top pane0 showed a similar mobility to the 93-kDa phosphotyrosine-containing band present in differentiated trophoblast cells (see Fig. 7 , bottom paneI).
Discussion
In this report, the Rcho-1 trophoblast cell line was used to examine the regulation of DNA synthesis in proliferating and differentiating trophoblast cells. The results indicate the utilization of different regulatory mechanisms for the control of DNA synthesis in proliferating VS. differentiating trophoblast cells and the dependence of each process on tyrosine kinase signaling pathways (see Fig. 8 for an overview) is a positive regulator of DNA synthesis in trophoblast stem cell cultures, and TGFpl is a negative regulator of trophoblast stem cell proliferation.
DNA synthesis in differentiating trophoblast cells appears to be under the control of an intrinsic mechanism(s). Differentiating trophoblast cells may secrete factors required to maintain DNA synthesis, or the maintenance of DNA synthesis may be an intrinsic part of the trophoblast giant cell differentiation program. Tyrosine kinases play an important role in the regulation of trophoblast cell proliferation and DNA synthesis. Unique tyrosine kinase activities and tyrosine phosphorylation patterns in proliferating and differentiating trophoblast cells suggest that tyrosine kinases may also be involved in these processes. P-Tyr, Tyrosine-phosphorylated proteins enriched in whole cell lysates from trophoblast stem cells or differentiating trophoblast cells.
Extracellular modulation of trophoblast cell DNA synthesis and proliferation
Proliferating and differentiating trophoblast cells respond differently to extracellular modulators. Trophoblast stem cells use extrinsic mechanisms (exogenous factors: serum, transferrin, and TGFPI) to regulate proliferation and DNA synthesis, whereas DNA synthesis in differentiating trophoblast cells is much less responsive to extracellular modulators and appears to be under the control of intrinsic mechanisms.
Extrinsic modulation of trophoblast stem cells. Rcho-1 trophoblast stem cell proliferation is maximally stimulated by factors present in FBS. The addition of other growth-related supplements has some of the actions of FBS, but none is fully capable of maintaining trophoblast stem cell proliferation. Transferrin is a positive regulator of DNA synthesis in trophoblast stem cells, but is not capable of completely replacing the growth-promoting properties of FBS. Other cells of the trophoblast lineage have also been shown to respond positively to transferrin (20) .
The identification of trophoblast cell growth modulatory factors has been elusive. In the present study, we were unable to identify factors that promote trophoblast stem cell proliferation. The placenta is a rich source of a variety of different growth factors and receptors for growth factors (19, 211, many of which have been proposed to regulate trophoblast cell proliferation. However, analysis of the literature does not provide convincing evidence for the identification of any growth factor that promotes trophoblast cell proliferation. There are a number of technical problems associated with studying the proliferation of trophoblast cells. First of all, trophoblast cell proliferation in vitro is an aberration. Upon removal from their in situ location, trophoblast cells spontaneously differentiate (2, 4, 22) . The factors necessary to prevent spontaneous differentiation have not been elucidated. Secondly, homogeneous cultures of primary trophoblast cells are difficult to obtain from any species. Some reports of in vitro growth promotion of placental cells are potentially confounded by nontrophoblast elements of the placenta (19, 22) . Finally, as DNA synthesis can be associated with trophoblast cell differentiation, the only reliable measure of trophoblast cell proliferation is an increase in trophoblast cell number. These apparent difficulties have made identification of factors that promote trophoblast cell proliferation an arduous task.
Nonetheless, we were successful in identifying a factor that negatively modulates trophoblast cell proliferation. TGFPl acts as an inhibitor of FBS-stimulated Rcho-1 trophoblast stem cell proliferation. These actions appear to be physiologically relevant given the localization of TGFPs in the uterine decidua (23,241. Furthermore, the actions of TGFPl are at sites distinct from modulation of trophoblast cell DNA synthesis and are, thus, compatible with endoreduplication and the presence of trophoblast giant cells at the placentaluterine interface. Inhibition of trophoblast cell proliferation may be a necessary first step in the differentiation pathway. The observations are also consistent with the proposed involvement of TGFPs in regulating trophoblast cell invasion in the human (23, 25) .
In these experiments, we used Rcho-1 trophoblast cells. Rcho-1 cells have undergone an unidentified transformation event(s) enabling them to proliferate in vitro (8, 9, 26, 27) . The nature of the aberration(s) in Rcho-1 trophoblast cells may account for their responses or lack of response to various growth modulators examined in this report. However, most importantly, Rcho-1 trophoblast stem cells are responsive to exogenous stimuli (FE%, transferrin, and TGFPl) and retain the ability to exit the proliferation program and progress along the trophoblast giant cell differentiation program (8,9).
Intrinsic modulation of differentiating trophoblast cells. In contrast to the extrinsic control of trophoblast stem cell DNA synthesis, differentiating trophoblast cells maximally synthesize DNA in the absence of serum and could not be stimulated above this intrinsic level. Modulators of DNA synthesis in proliferating trophoblast cells (serum, transferrin, and TGFPl) had minimal, if any, detectable effects on DNA synthesis in differentiating trophoblast cells. Thus, the nature of the control of DNA synthesis during the endocycle of giant cells may be quite different from that during the cell cycle of diploid cells. Giant cells may secrete factors required for progression of the endocycle. These factors may be the same as those required for progression through the cell cycle of trophoblast stem cells. Preliminary experiments examining the effects of conditioned medium from differentiated trophoblast cells on proliferation or DNA synthesis of trophoblast stem cells did not support this hypothesis (Hamlin, G. P., and M. J. Soares, unpublished results). Alternatively, giant cells may secrete unique regulatory molecules or may use unique intracellular mechanisms for controlling DNA synthesis that bypass extracellular activation.
Tyrosine kinase pathways and trophoblast cells Our difficulty in elucidating extracellular modulators of trophoblast cell proliferation and differentiation led to an analysis of intracellular pathways used by trophoblast stem cells and differentiating trophoblast cells. We report here the involvement of tyrosine kinase-activated pathways in the control of trophoblast stem cell DNA synthesis and proliferation and in the control of DNA synthesis in differentiating trophoblast cells.
Treatment of stem and differentiating trophoblast cells with the tyrosine kinase inhibitor, genistein, disrupted the abilities of the cells to proliferate and/or synthesize DNA. The related tyrosine kinase inhibitor, lavendustin-A, was ineffective at influencing the behavior of trophoblast stem and differentiating cells even at high doses. In other systems, lavendustin-A and genistein have been reported to possess different effects (28, 29) . Genistein is a well documented broad spectrum inhibitor of both receptor (30-32) and nonreceptor (30,33,34) tyrosine kinase pathways. Both receptor and nonreceptor tyrosine kinases have been implicated in the control of the growth and differentiation of a number of different cell lineages (3537). DNA synthesis in trophoblast stem cells and differentiating trophoblast cells may involve nonreceptor tyrosine kinase signaling pathways. This postulate is consistent with the absence of stimulation of DNA synthesis in trophoblast stem cells treated with a number of ligands known to activate receptor tyrosine kinases (present study) and the differential activation of three members of the src family of nonreceptor tyrosine kinases (src, yes, and Zyn) during the transition from trophoblast cell proliferation to differentiation (Hamlin, G. P., and M. J. Soares, unpublished results).
Although tyrosine kinase activities were detectable in both proliferating and differentiating trophoblast cells, there were significant differences in their levels. Tyrosine kinase activities in PBS-or transferrin-treated trophoblast stem cells were considerably higher than those in differentiating trophoblast cells. This observation may be related to the types of tyrosine kinases present in proliferating VS. differentiating trophoblast cells. Different tyrosine kinases may possess different substrate specificities. Consequently, tyrosine kinases present in each cell population may differ in their abilities to use the synthetic peptide (RR-Src) containing the c-src consensus tyrosine phosphorylation site used in our analysis of tyrosine kinase activity. Such a hypothesis is further supported by the unique distributions of phosphotyrosine-contaming proteins in proliferating VS. differentiating trophoblast cells. Trophoblast stem cells stimulated to proliferate or differentiate were characterized by both the loss and gain of specific phosphotyrosine-containing proteins. Most interestingly, TGFP treatment, which appears to be capable of initiating the exit of trophoblast stem cells from the proliferation program, was associated with the appearance of a 93-kDa phosphotyrosine-containing protein also present in differentiated trophoblast cells. Determination of the identity of the 93-kDa and other unique phosphotyrosine-containing proteins and the kinases responsible for their phosphorylation should provide information regarding up-and downstream regulatory events involved in trophoblast cell proliferation, DNA synthesis, and differentiation.
In conclusion, regulatory mechanisms controlling DNA synthesis in trophoblast cells differ depending on their differentiation state. Proliferating trophoblast cells are under extrinsic control, whereas differentiating trophoblast cells are under intrinsic control. Tyrosine kinase-mediated signal transduction pathways are involved in the regulation of trophoblast cell proliferation, DNA synthesis, and differentiation. of extraembryonic cell lineages in the mouse embryo.
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